Your browser doesn't support javascript.
loading
Reply To the Editor, Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315.
Bicakli, Derya Hopanci; Varol, Umut; Degirmenci, Mustafa; Tunali, Didem; Cakar, Burcu; Durusoy, Raika; Karaca, Burcak; Sanli, Ulus Ali; Uslu, Ruchan.
Afiliação
  • Bicakli DH; Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege University, Turkey.
  • Varol U; Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege University, Turkey varolumut@yahoo.com.
  • Degirmenci M; Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege University, Turkey.
  • Tunali D; Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege University, Turkey.
  • Cakar B; Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege University, Turkey.
  • Durusoy R; Department of Public Health, School of Medicine, Ege University, Turkey.
  • Karaca B; Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege University, Turkey.
  • Sanli UA; Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege University, Turkey.
  • Uslu R; Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege University, Turkey.
J Oncol Pharm Pract ; 21(4): 318-9, 2015 Aug.
Article em En | MEDLINE | ID: mdl-25979298

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Quimioterapia Adjuvante / Síndrome Metabólica Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: J Oncol Pharm Pract Assunto da revista: FARMACIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Turquia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Quimioterapia Adjuvante / Síndrome Metabólica Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: J Oncol Pharm Pract Assunto da revista: FARMACIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Turquia